Author: Daniel Schmidtmann

  • HEDIMED Toolbox

    Project Newsletter | 2025 HEDIMED Toolbox Dear HEDIMED community,  The HEDIMED Toolbox is now live an accessible through our website! Here is an overview of the available tools: Array-in-Well (AiW) multiplex assay platform 1H NMR spectrometry for analysis of biological samples Allergens screening tool: portable flouresence biosensing reader Data analysis methods for analyzing Olink proteomics…

  • Event summary

    Project Newsletter | 2025 | extra event issue Event summary Dear HEDIMED community, thank you all for participating in our event! We successfully delivered an overview of our project’s research results, achievements in technology, and implications for policy making. Over 100 participants from 28 countries around the world attended the event, including researchers from universities,…

  • Upcoming HEDIMED Event! Tuesday 20 May 2025 09:00 – 15:00 CET

    Project Newsletter | 2025 | extra event issue Dear HEDIMED community, we invite you to attend the Environment & Immune-mediated diseases: Exposomic Insights from the HEDIMED Project HEDIMED, Final Stakeholder Event on Tue 20th May 2025, online. Our EU-funded HEDIMED project started in 2020 investigating the role of the exposome in immune-mediated diseases. The exposome includes all lifetime exposures of an individual…

  • HEDIMED in horizon magazine

    HEDIMED was featured in the European Commission’s Horizon Research & Innovation Magazine. Read the article “The hunt for clues to immune-system disorders” on how HEDIMED is taking approaches to understanding a growing group of illnesses in a bid for more effective treatments. https://projects.research-and-innovation.ec.europa.eu/en/horizon-magazine/hunt-clues-immune-system-disorders

  • Newsletter #4

    Project Newsletter | Winter 2023/24 Recapping our research focus Our first paper described the overall design of the HEDIMED project. It was published as a review article together with other European Human Exposome Projects in the Journal of Environmental Epidemiology. The main goal summarizes well the key determinants: “The main goal of HEDIMED is to…

  • Newsletter #3

    Project Newsletter | Newsflash Invitation to HEDIMED public platform development questionnaire Are you interested in the exposome or immune mediated diseases? Help us develop a TOOLBOX on these topics that fits your needs! HEDIMED aims at assessing and addressing the impact of environment on health by investigating the role of the exposome in immune-mediated diseases. As…

  • Newsletter #2

    Project Newsletter | Winter2022 HEDIMED @ ICDS2022 Our consortium lead is delighted to see our committed partners spreading the exposomic message of HEDIMED! This October, the project received attention and interest in Italy, at the International Celiac Disease Symposium, ICDS2022. ICDS is considered a key forum for both the scientific community and the stakeholders, aiming…

  • Newsletter #1

    Project Newsletter | Spring 2022 Coordinator’s greetings I’m happy to introduce you HEDIMED, a large research consortium which seeks for solutions to a huge medical and socio-economic problem – immune mediated diseases. These diseases are common, and increasing rapidly in developed countries, and environmental factors are driving this increase. However, many of these factors are…